V3MA:XETRA:XETRA-Vanguard ESG Emerging Markets All Cap UCITS ETF USD Acc EUR (EUR)

ETF | Others |

Last Closing

USD 6.228

Change

-0.03 (-0.42)%

Market Cap

N/A

Volume

21.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict
Created with Highstock 5.0.6

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
V3MA:XETRA
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.01 (+0.02%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

-2.36 (-2.65%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.27 (-1.30%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.12 (-1.01%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.07 (-1.51%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.31 (-1.50%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.31 (-2.68%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.28 (-0.52%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.32 (-3.43%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.93 (-0.78%)

USD 12.26B

ETFs Containing V3MA:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.72% 38% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.72% 40% F 39% F
Trailing 12 Months  
Capital Gain 10.11% 82% B 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.11% 82% B 78% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.90% 51% F 52% F
Dividend Return 6.90% 50% F 50% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.33% 68% D+ 75% C
Risk Adjusted Return 82.85% 71% C- 75% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.